NASDAQ
PharmaCyte Biotech, Inc. (PMCB) has a current ratio of 7.68x as of Monday, May 25, 2026. This represents a 87.59% decrease compared to its 12-month average of 61.87x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.